BioCardia, Inc.: presents CardiAMP HF II trial design at HFSA meeting

What happened On Oct 7, 2026, BioCardia, Inc. issued a press release reporting that BioCardia presents CardiAMP HF II Trial design at the Heart Failure Society of America Annual Scientific Meeting. The filing states the press release was furnished under Item 8.01 of the Form 8-K.

Key details

• Date filed: Oct 7, 2026.
• Event: presentation of the CardiAMP HF II Trial design at the Heart Failure Society of America Annual Scientific Meeting.
• Form 8-K item reported: Item 8.01, other events.
• The press release was referenced in the filing.

Why it may matter Item 8.01 was reported, which covers other events disclosed by the company such as press releases about presentations or developments. The filing does not show why the insider traded or why the company acted.